Journal of Enzyme Inhibition and Medicinal Chemistry (Jan 2020)

Antitumor properties of certain spirooxindoles towards hepatocellular carcinoma endowed with antioxidant activity

  • Sara T. Al-Rashood,
  • Ahmed R. Hamed,
  • Ghada S. Hassan,
  • Hamad M. Alkahtani,
  • Abdulrahman A. Almehizia,
  • Amal Alharbi,
  • Mohammad M. Al-Sanea,
  • Wagdy M. Eldehna

DOI
https://doi.org/10.1080/14756366.2020.1743281
Journal volume & issue
Vol. 35, no. 1
pp. 831 – 839

Abstract

Read online

In the current medical era, spirooxindole motif stands out as a privileged heterospirocyclic scaffold that represents the core for a wide range of bioactive naturally isolated products (such as Strychnofoline and spirotryprostatins A and B) and synthetic compounds. Interestingly, no much attention has been paid to develop spirooxindole derivatives with dual antioxidant and anticancer activities. In this context, a series of spirooxindoles 6a-p was examined for their anticancer effect towards HepG2 hepatocellular carcinoma and PC-3 prostate cancer cell lines. Spirooxindole 6a was found to be an efficient anti-proliferative agent towards both HepG2 and PC-3 cells (IC50 = 6.9 and 11.8 µM, respectively). Afterwards, spirooxindole 6a was assessed for its apoptosis induction potential in HepG2 cells, where its pro-apoptotic impact was approved via the significant elevation in the Bax/Bcl-2 ratio and the expression levels of caspase-3,

Keywords